Illumina Given New $175.00 Price Target at Mizuho (ILMN)
Stock analysts at Mizuho boosted their price target on shares of Illumina (NASDAQ:ILMN) from $150.00 to $175.00 in a report issued on Wednesday, American Banking and Market News reports. The firm currently has a “buy” rating on the stock. Mizuho’s price objective would indicate a potential upside of 21.08% from the stock’s previous close.
In other Illumina news, CEO Jay Flatley unloaded 30,000 shares of the company’s stock in a transaction that occurred on Thursday, January 23rd. The stock was sold at an average price of $142.30, for a total transaction of $4,269,000.00. Following the sale, the chief executive officer now directly owns 399,509 shares in the company, valued at approximately $56,850,131. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
Illumina (NASDAQ:ILMN) opened at 144.53 on Wednesday. Illumina has a 1-year low of $48.00 and a 1-year high of $148.48. The stock’s 50-day moving average is $116.1 and its 200-day moving average is $92.29. The company has a market cap of $18.268 billion and a P/E ratio of 167.36.
Illumina (NASDAQ:ILMN) last released its earnings data on Tuesday, January 28th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.44 by $0.01. The company had revenue of $387.00 million for the quarter, compared to the consensus estimate of $382.06 million. During the same quarter in the previous year, the company posted $0.42 earnings per share. The company’s revenue for the quarter was up 25.1% on a year-over-year basis. Analysts expect that Illumina will post $1.78 EPS for the current fiscal year.
Several other analysts have also recently commented on the stock. Analysts at ISI Group raised their price target on shares of Illumina from $134.50 to $147.00 in a research note to investors on Wednesday. They now have a “neutral” rating on the stock. Separately, analysts at Leerink Swann raised their price target on shares of Illumina from $110.00 to $140.00 in a research note to investors on Friday, January 17th. Finally, analysts at Bank of America Corp. raised their price target on shares of Illumina from $125.00 to $165.00 in a research note to investors on Friday, January 17th. Seven investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $118.78.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.